EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells

INTRODUCTION: Inflammatory breast cancer (IBC) is the most metastatic variant of breast cancer with the poorest survival in all types of breast cancer patients and presently therapeutic targets for IBC are very limited. Enhancer of zeste homolog 2 (EZH2) is frequently expressed in human IBC and its...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Zhaomei, Li, Hua, Fernandez, Sandra V, Alpaugh, Katherine R, Zhang, Rugang, Cristofanilli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850122/
https://www.ncbi.nlm.nih.gov/pubmed/24294976
http://dx.doi.org/10.1186/1756-9966-32-70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850122/
https://www.ncbi.nlm.nih.gov/pubmed/24294976
http://dx.doi.org/10.1186/1756-9966-32-70

Ejemplares similares